CAS 199803-23-1
:3-CHLORO-2-[(4-METHYLPHENYL)THIO]ANILINE
Description:
3-Chloro-2-[(4-methylphenyl)thio]aniline is an organic compound characterized by its aromatic structure, which includes a chloro substituent and a thioether group. The presence of the chloro group introduces a polar functional group that can influence the compound's reactivity and solubility. The thioether linkage, involving a sulfur atom bonded to a phenyl group, contributes to the compound's overall stability and can affect its electronic properties. This compound is likely to exhibit moderate to high lipophilicity due to the presence of aromatic rings, which can facilitate interactions with biological systems. Additionally, the presence of the aniline moiety suggests potential for hydrogen bonding, which may influence its solubility in various solvents. The compound may be of interest in pharmaceutical or agrochemical applications, given the structural features that can be associated with biological activity. Safety and handling precautions should be observed, as compounds containing chlorine and sulfur can pose health and environmental risks.
Formula:C13H12ClNS
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
3-Chloro-2-[(4-methylphenyl)sulfanyl]aniline
CAS:3-Chloro-2-[(4-methylphenyl)sulfanyl]aniline is a monoclonal antibody that binds to the CB2 receptor. It is used as an immunosuppressant in the treatment of autoimmune diseases, inflammatory diseases, and cancer. 3-Chloro-2-[(4-methylphenyl)sulfanyl]aniline has been shown to inhibit the proliferation of colorectal carcinoma cells by blocking the activity of the receptor for prostaglandin E2 (PGE2). This drug also inhibits inflammatory responses by binding to receptors that are involved in inflammation and immune response. 3-Chloro-2-[(4-methylphenyl)sulfanyl]aniline is metabolized through ester hydrolysis or oxidation to form 3-(3' chloropropoxy)-2-[(4'-methylphenyl)sulfanyl]aniline, which may be responsibleFormula:C13H12ClNSPurity:Min. 95%Molecular weight:249.76 g/mol


